Investing in the future of essential societal systems.

Innovative technologies with proprietary foundations and the potential to fundamentally improve how essential systems function. The focus is on breakthrough solutions across health, agrifood, and renewable chemistry that address root causes, demonstrate clear technical defensibility, and are designed for real-world application, often within complex or regulated environments.

Founders and teams with deep domain expertise, strong execution capability, and clear growth ambition. We look for teams built around a proprietary technology, with the discipline to translate innovation into a scalable business and a shared ambition to build towards a clear exit.

With our current fund we invest at the Seed to Series A stage, with initial ticket sizes ranging from €250k to €2M, focusing on companies based in Europe. We act as active, long-term partners, supporting founders through key phases of company building, from early validation and strategy to scaling and beyond. Impact is not an afterthought; it informs how we select investments, how we support teams, and how we measure success over time.